DNA Vaccine Development at Pre- and Post-Operation Warp Speed

K. Ljungberg, M. Isaguliants,

2020

https://doi.org/10.3390/vaccines8040737

DNA is a rapidly developing vaccine platform for combatting cancer, infectious and noninfectious diseases [...].

Цитирование

Об авторах

K. Ljungberg
Eurocine Vaccines AB, Fogdevreten 2, 17165 Solna, Sweden;, karl.ljungberg@eurocine-vaccines.com
M. Isaguliants
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden, Department of Research, Riga Stradins University, LV-1007 Riga, Latvia, N.F. Gamaleya Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia, M.P. Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, 108819 Moscow, Russia

Название журнала

Том

Выпуск

Страницы

Издатель

Тип документа

Тип лицензии Creative Commons

Правовой статус документа

Источник